Publications by authors named "Jill Davis"

Claim this Profile
L
Local level of social inequity moderates implementation of evidence-based practices tailored to minoritized populations to reduce opioid overdose deaths.
Avik Chatterjee, Rachel P Chase, Rouba A Chahine, Jill Davis, Nishi Dsouza, Alissa Davis

J Subst Use Addict Treat· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Digital Divide and Tele-MOUD: A Qualitative Study of Opioid Community Coalition Perspectives During COVID-19.
Sadie Chen, Alison Aldrich, Shaquita Andrews-Higgins, Sandra Back-Haddix, Mary Bartkus, Jill Davis

Telemed J E Health· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reach of Community-Selected Strategies to Reduce Opioid-Related Overdose Deaths in the HEALing Communities Study.
Megan E Hall, LaShawn Glasgow, JaNae Holloway, Rouba A Chahine, Jill Davis, Alissa Davis

Subst Use Misuse· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community coalitions' navigation of policies to address the opioid epidemic: insights from qualitative interviews in four states.
Ramona G Olvera, Allyson G Cogan, Mary Bartkus, Shoshana N Benjamin, Jill Davis

BMJ Public Health· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of anaemia in adults with chronic kidney disease in a representative sample of the United States population: analysis of the 1999-2018 National Health and Nutrition Examination Survey.
Csaba P Kovesdy, Jill R Davis, Ian Duling, Dustin J Little

Clin Kidney J· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of predialysis hyperkalemia and associated characteristics among hemodialysis patients: The RE-UTILIZE study.
Abiy Agiro, Ian Duling, James Eudicone, Jill Davis, Yasmin G Brahmbhatt

Hemodial Int· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualitative Methodology for Planning and Executing In-Person and Virtual Neurosurgery Educational Opportunities for Medical Students: Lessons Learned from Five Years of Medical Student Neurosurgery Training Center Initiatives.
Ryan E Radwanski, Michael W Kortz, Michael Rothbaum, Kyle Zappi, Nathan A Shlobin, Jill L Davis

World Neurosurg· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Management of Hyperkalemia in the Emergency Department: An Electronic Medical Record Analysis.
Jill Davis, Rubeen Israni, Keith A Betts, Fan Mu, Erin E Cook

Adv Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of Hyperkalemia Progression Among Patients with Mild Hyperkalemia.
Rubeen Israni, Keith A Betts, Fan Mu, Jill Davis, Jessie Wang

Adv Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inpatient management and post-discharge outcomes of hyperkalemia.
Jill Davis, Rubeen Israni, Fan Mu, Erin E Cook, Harold Szerlip

Hosp Pract (1995)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Metabolic Acidosis Among Patients with Chronic Kidney Disease and Hyperkalemia.
Erin E Cook, Jill Davis, Rubeen Israni, Fan Mu, Keith A Betts

Adv Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of clinically significant thresholds of eosinophil elevation on health care resource use in asthma.
Zenobia Dotiwala, Julian Casciano, Jill R Davis, Kathleen Fox, Gokul Gopalan

Ann Allergy Asthma Immunol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budesonide/formoterol therapy: effective and appropriate use in asthma and chronic obstructive pulmonary disease.
Douglas W Mapel, Melissa H Roberts, Jill Davis

J Comp Eff Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drivers of health care costs for adults with persistent asthma.
Robert S Zeiger, Trung N Tran, Michael Schatz, Qiaowu Li, Wansu Chen, Jill Davis

J Allergy Clin Immunol Pract· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of asthma among patients adherent to ICS/LABA: A real-world study.
Jill Davis, Frank Trudo, James Siddall, Mark Small

J Asthma· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma.
Jaco Voorham, Xiao Xu, David B Price, Sarowar Golam, Jill Davis

Allergy· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing patients with asthma who received Global Initiative for Asthma steps 4-5 therapy and managed in a specialty care setting.
Brian Stone, Jill R Davis, Frank Trudo, Bradd Schiffman, Carlos Alzola

Allergy Asthma Proc· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Nonadherence to Inhaled Corticosteroid/LABA Therapy on COPD Exacerbation Rates and Healthcare Costs in a Commercially Insured US Population.
Jill R Davis, Bingcao Wu, David M Kern, Ozgur Tunceli, Kathleen M Fox

Am Health Drug Benefits· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments.
Frank Trudo, David M Kern, Jill R Davis, Ozgur Tunceli, Siting Zhou

Int J Chron Obstruct Pulmon Dis· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population.
David M Kern, Jill Davis, Setareh A Williams, Ozgur Tunceli, Bingcao Wu

Int J Chron Obstruct Pulmon Dis· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Care Utilization and Costs After Initiating Budesonide/Formoterol Combination or Fluticasone/Salmeterol Combination Among COPD Patients New to ICS/LABA Treatment.
Jill R Davis, David M Kern, Setareh A Williams, Ozgur Tunceli, Bingcao Wu

J Manag Care Spec Pharm· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study.
David M Kern, Jill Davis, Setareh A Williams, Ozgur Tunceli, Bingcao Wu

Respir Res· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ambulatory blood pressure monitoring should be used in the primary care setting to diagnose hypertension.
T Keefe Davis, A Jill Davis

Am J Hypertens· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure to hazardous drugs in healthcare: an issue that will not go away.
Jill Davis, Robert McLauchlan, Thomas H Connor

J Oncol Pharm Pract· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis